Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 366 publications
Upadacitinib monotherapy versus methotrexate monotherapy in methotrexate-naïve Japanese patients with rheumatoid arthritis: Long-term efficacy and safety through 5 years in the SELECT-EARLY study.
Journal: Modern rheumatology
Published: February 12, 2026
Upadacitinib monotherapy versus methotrexate monotherapy in methotrexate-naïve Japanese patients with rheumatoid arthritis: long-term efficacy and safety through 5 years in the SELECT-EARLY study.
Journal: Modern rheumatology
Published: February 12, 2026
Interobserver variability in synovial tissue biopsy markers in Rheumatoid Arthritis: Results from OMERACT special interest group on synovial tissue biopsy.
Journal: Seminars in arthritis and rheumatism
Published: February 06, 2026
Sex differences in the efficacy, safety and persistence of tofacitinib in patients with rheumatoid arthritis: a post hoc analysis of phase III and long-term extension trials.
Journal: BMJ open
Published: December 25, 2025
Olokizumab Improves Patient-Reported Outcomes in Patients with Active Rheumatoid Arthritis up to 106 Weeks (Results from the Open-Label Extension of Phase III Randomized Clinical Trials).
Journal: Rheumatology and therapy
Published: December 08, 2025
Report From the 2024 International Dermatology Outcome Measures (IDEOM) Annual Meeting.
Journal: Journal of drugs in dermatology : JDD
Published: December 02, 2025
Qualitative interview study in patients with SLE to assess patient perception of fatigue and skin-related symptoms.
Journal: Lupus science & medicine
Published: November 19, 2025
Composite outcome measures that successfully differentiate active treatments from placebo in psoriatic arthritis trials: a GRAPPA-OMERACT systematic review and network meta-analysis.
Journal: Annals of the rheumatic diseases
Published: October 19, 2025
Development of a single‑item patient‑reported measure of treatment side‑effect burden in clinical trials of rheumatic and musculoskeletal diseases using stakeholder input and large language model refinement.
Journal: Seminars in arthritis and rheumatism
Published: October 15, 2025
Reassessing antimalarial use in long-term SLE clinical trials - Authors' reply.
Journal: The Lancet. Rheumatology
Published: June 12, 2025
Last Updated: 09/26/2026